Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
about
Biology of parainfluenza virusesParainfluenza virusesPathogenesis of acute respiratory illness caused by human parainfluenza virusesProgress in the development of human parainfluenza virus vaccinesVaccinia virus vectors: new strategies for producing recombinant vaccines.The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivoCytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus.Intracellular processing and transport of NH2-terminally truncated forms of a hemagglutinin-neuraminidase type II glycoprotein.Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenThe cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumoniaHomooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity.Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antAntigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challengeVaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challengeSynthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene.Current approaches to the development of vaccines effective against parainfluenza viruses.Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infectionPassive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.Current management of parainfluenza pneumonitis in immunocompromised patients: a review.Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase.Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses.High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system.Characterizing the Cellular Immune Response to Parainfluenza Virus 3.The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.
P2860
Q24615805-0D539F28-DA85-4DC0-9A51-7534BF65EE95Q24682952-C95DCF75-11C9-4DF5-B9ED-349F6F50C752Q27000151-CF5D6C66-56D0-4BE9-8748-1E5B6943C835Q34209872-03C9A281-E8D0-4F5E-A276-5E4F4B7BF4F4Q34211635-8A1F5F90-EE3A-421F-BA29-272964CF7B46Q35111071-FB22FAD4-DF17-4750-ADC1-DC782690C1F6Q35833059-2842571E-DB74-45B0-9C1B-F2205A84661EQ36223225-97C26C27-BAF4-4E8D-9898-7AFB4DF83A42Q36433111-6295AE4D-917E-42B3-9D10-F4769F3403D0Q36641979-0D616249-4CFC-4A00-A545-7807049E71B0Q36650105-22AB9AB6-0C4C-4217-AC8E-9462CE0DE033Q36683018-B41B0F01-38D3-4F00-A47C-4C8D2F91954DQ36687812-383581E3-D530-4CAE-AD10-09B48789E00BQ36688653-9A41568E-3BCC-4ADC-B83F-5CC38B843A64Q36691093-8003DD26-B0E8-447E-8D60-62E9B8D6D597Q36780319-0461F51F-6527-4C87-8707-E7E25E009823Q36784384-CC475DBD-E1EE-466F-9D38-CA126E5C4056Q36797309-B948F93D-AFEF-4AE5-BD1A-582CCC413970Q36798265-106F4550-414F-484D-BFCE-F772B162927CQ36799591-427C7D46-C7BC-446D-8C18-20D4B13F9FB4Q36830350-45513172-1393-4E5F-8E32-34A223502C96Q36866184-74BC59DE-2999-4B13-8B34-B8F790D3B3CCQ36873249-5E16125E-538C-404A-916A-F61659DD7653Q36875715-D620A5E2-9F89-4CFF-B9E6-D5B35CB84DC7Q37348134-0391EC6C-8A86-453A-821A-A9822D78A59AQ38034753-EBFF3B0D-4B8A-44F7-862D-2916D5BB0BCDQ38331870-B67A40AB-9A50-425C-B942-F4E7B04ACC30Q39870704-6B6427BE-EB6F-427A-BDDA-CB6DA2A83229Q39877929-A4E52FF6-FE33-430A-B609-54D326C41D59Q40130193-81C1AADD-6E6F-43F8-83B8-8DE9AB1E29ADQ40215048-FB7F094F-450B-4FFD-B70C-41D14E338C80Q42174484-12EBB986-1EB3-465A-B660-4367551ECCEC
P2860
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Expression of the F and HN gly ...... ual proteins to host immunity.
@en
type
label
Expression of the F and HN gly ...... ual proteins to host immunity.
@en
prefLabel
Expression of the F and HN gly ...... ual proteins to host immunity.
@en
P2093
P2860
P1433
P1476
Expression of the F and HN gly ...... ual proteins to host immunity.
@en
P2093
P2860
P304
P407
P577
1987-11-01T00:00:00Z